TargetSerine/threonine-protein kinase Chk2(Human)
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 15nMAssay Description:Inhibition of human recombinant Chk2More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase Chk2(Human)
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 15nMAssay Description:Inhibition of Chk2Checked by AuthorMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase Chk2(Human)
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 15nMAssay Description:Inhibition of recombinant human Chk2 kinaseMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase Chk2(Human)
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 15nMAssay Description:Inhibition of Chk2Checked by AuthorMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase Chk2(Human)
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 16nMAssay Description:Inhibition of chk2 kinaseMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase Chk2(Human)
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 16nMAssay Description:Inhibition of recombinant human Chk2 kinaseMore data for this Ligand-Target Pair
Affinity DataIC50: 100nMpH: 7.5 T: 30°CAssay Description:NSC 109555 was diluted in water. All other drugs were dissolved in DMSO, in which case the final DMSO concentration in reactions was 10%, and the con...More data for this Ligand-Target Pair